Brain Glucose Metabolism in Cerebral Amyloid Angiopathy: An FDG-PET Study

Sébastien Bergeret1, Mathieu Queneau2, Mathieu Rodallec3

  • 1Department of Nuclear Medicine, CHU de Martinique, Université des Antilles, Fort-de-France (S.B., K.F.).

Stroke
|February 22, 2021
PubMed

Insights

Cerebral amyloid angiopathy (CAA) diagnosis may improve with 18F-fluoro-deoxy-D-glucose (FDG) PET scans showing reduced glucose uptake in posterior brain regions. This finding supports FDG-PET as a potential diagnostic tool for CAA.

Area of Science:

  • Neurology
  • Neuroimaging
  • Metabolic Brain Imaging

Background:

  • Cerebral amyloid angiopathy (CAA) diagnosis relies on Boston criteria, primarily using MRI for hemorrhagic features.
  • 18F-fluoro-deoxy-D-glucose (FDG) positron emission tomography (PET) is a widely available imaging modality with potential to enhance CAA diagnostic accuracy.

Purpose of the Study:

  • To test the hypothesis that FDG uptake is reduced in posterior cortical areas in patients with probable CAA.
  • To investigate the utility of FDG-PET in identifying hypometabolism in specific brain regions affected by vascular Aβ deposition.

Main Methods:

  • Retrospective analysis of 14 patients meeting Boston criteria for probable CAA who underwent both MRI and FDG-PET.
  • FDG-PET data processed for spatial normalization and generation of relative standardized uptake values (SUVR) in 13 regions of interest.
  • Comparison of SUVR between CAA patients and age-matched controls using two healthy subject databases and image-processing pipelines.

Main Results:

  • Significant hypometabolism was consistently observed in posterior cortical areas, including parietal, visual, temporal, precuneus, and posterior cingulate regions.
  • Anterior cortical areas showed marginal or no significant hypometabolism.
  • The cerebellum was not significantly affected, indicating region-specific metabolic changes in CAA.

Conclusions:

  • FDG-PET reveals significant glucose hypometabolism predominantly in posterior cortical regions, supporting its diagnostic potential for CAA.
  • Findings suggest FDG-PET can identify metabolic changes associated with vascular Aβ deposition in the visual cortex and other posterior areas.
  • Further validation in larger prospective studies is needed to confirm these diagnostic implications and explore generalization to symptomatic CAA.
Abstract

Related Concept Videos